天宇股份股价涨5.07%，湘财基金旗下1只基金重仓，持有27.38万股浮盈赚取36.14万元

Group 1 - Tianyu Co., Ltd. experienced a stock price increase of 5.07%, reaching 27.36 CNY per share, with a trading volume of 1.01 billion CNY and a turnover rate of 1.79%, resulting in a total market capitalization of 9.521 billion CNY [1] - The company, established on February 14, 2003, and listed on September 19, 2017, is located in Taizhou, Zhejiang Province, and specializes in the production and sales of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), formulations, and other fine chemicals, along with import and export of goods and technology [1] - The revenue composition of Tianyu Co., Ltd. includes 72.18% from generic APIs and intermediates, 16.02% from CDMO APIs and intermediates, 11.43% from formulations, and 0.36% from other supplementary products [1] Group 2 - Xiangcai Fund has a significant holding in Tianyu Co., Ltd., with its Xiangcai Medical Health Mixed A Fund (019958) increasing its stake by 20,480 shares in the third quarter, bringing the total to 273,800 shares, which accounts for 9.85% of the fund's net value, making it the second-largest holding [2] - The Xiangcai Medical Health Mixed A Fund, established on December 26, 2023, has a latest scale of 17.2816 million CNY, with a year-to-date return of 50.18%, ranking 1080 out of 8140 in its category, and a one-year return of 37.18%, ranking 1452 out of 8056 [2] - The fund manager, Zhang Quan, has been in the position for 1 year and 325 days, overseeing a total asset scale of 71.7344 million CNY, with the best fund return during his tenure being 72.41% and the worst being 71.65% [3]